drugset / Trial / NCT05056935
Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to establish preliminary evidence of the efficacy, safety, and tolerability of LB1148 for the treatment of return of gastrointestinal function and decrease Post-Operative Ileus in subjects undergoing elective bowel resection.
Timeline
- Start
- 2019-07-09
- Primary completion
- 2020-07-22
- Completion
- 2020-08-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 700 ml | Oral |